MSB 6.57% 99.5¢ mesoblast limited

Regenerative Medicine and Cell Therapies Virtual Event, page-105

  1. 3,215 Posts.
    lightbulb Created with Sketch. 951
    Techfan, thanks for posting.

    Where are you getting your pricing from, may I ask? Reason I ask is that with preferred nation status, maybe it would be more like US$113,000 (maybe say now US$120k due to exchange rate...?) rather than $160K? ($20k per dose * 8 doses) if I go on the below:

    Reimbursement for TEMCELL has been authorized by NHI at ÂĄ868,680 (A$9,767 / US$7,079) per bag of 72 million cells. In Japan, the average adult patient is expected to receive 16 or up to 24 bags of 72 million cells. On this basis, Mesoblast expects a treatment course of TEMCELL in an adult Japanese patient to be reimbursed at ÂĄ13,898,880 (A$156,000 / US$113,000) or up to ÂĄ20,848,320 (A$234,000 / US$170,000).




    https://www.globenewswire.com/news-release/2015/11/27/790909/0/en/Mesoblast-s-Japan-Licensee-Receives-Pricing-for-TEMCELL-HS-Inj-for-Treatment-of-Acute-Graft-Versus-Host-Disease.html

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
99.5¢
Change
-0.070(6.57%)
Mkt cap ! $1.136B
Open High Low Value Volume
$1.04 $1.04 99.5¢ $3.980M 3.944M

Buyers (Bids)

No. Vol. Price($)
8 56239 99.5¢
 

Sellers (Offers)

Price($) Vol. No.
$1.00 103125 2
View Market Depth
Last trade - 16.10pm 04/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.